Diaceutics DIUXF Stock
Diaceutics Price Chart
Diaceutics DIUXF Financial and Trading Overview
Diaceutics stock price | 1.37 USD |
Previous Close | 1.12 USD |
Open | 1.12 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 1.12 - 1.12 USD |
52 Week Range | 1.12 - 1.38 USD |
Volume | 2K USD |
Avg. Volume | 0 USD |
Market Cap | 94.61M USD |
Beta (5Y Monthly) | 0.324964 |
PE Ratio (TTM) | 112 |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
DIUXF Valuation Measures
Enterprise Value | 75.86M USD |
Trailing P/E | 112 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 4.8507533 |
Price/Book (mrq) | 2.2178218 |
Enterprise Value/Revenue | 3.89 |
Enterprise Value/EBITDA | 36.544 |
Trading Information
Diaceutics Stock Price History
Beta (5Y Monthly) | 0.324964 |
52-Week Change | -18.86% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.38 USD |
52 Week Low | 1.12 USD |
50-Day Moving Average | 1.12 USD |
200-Day Moving Average | 1.12 USD |
DIUXF Share Statistics
Avg. Volume (3 month) | 0 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 84.47M |
Float | 46.53M |
Short Ratio | N/A |
% Held by Insiders | 46.78% |
% Held by Institutions | 47.41% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 3.71% |
Operating Margin (ttm) | 2.94% |
Gross Margin | 85.83% |
EBITDA Margin | 10.64% |
Management Effectiveness
Return on Assets (ttm) | 0.77% |
Return on Equity (ttm) | 1.74% |
Income Statement
Revenue (ttm) | 19.5M USD |
Revenue Per Share (ttm) | 0.23 USD |
Quarterly Revenue Growth (yoy) | 50.10% |
Gross Profit (ttm) | 16.74M USD |
EBITDA | 2.08M USD |
Net Income Avi to Common (ttm) | 724K USD |
Diluted EPS (ttm) | 0.01 |
Quarterly Earnings Growth (yoy) | 66.40% |
Balance Sheet
Total Cash (mrq) | 19.84M USD |
Total Cash Per Share (mrq) | 0.24 USD |
Total Debt (mrq) | 1.33M USD |
Total Debt/Equity (mrq) | 3.13 USD |
Current Ratio (mrq) | 8.235 |
Book Value Per Share (mrq) | 0.505 |
Cash Flow Statement
Operating Cash Flow (ttm) | 5.1M USD |
Levered Free Cash Flow (ttm) | -354625 USD |
Profile of Diaceutics
Country | United States |
State | N/A |
City | Belfast |
Address | Building Two |
ZIP | BT9 6GW |
Phone | N/A |
Website | https://www.diaceutics.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 151 |
Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Q&A For Diaceutics Stock
What is a current DIUXF stock price?
Diaceutics DIUXF stock price today per share is 1.37 USD.
How to purchase Diaceutics stock?
You can buy DIUXF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Diaceutics?
The stock symbol or ticker of Diaceutics is DIUXF.
Which industry does the Diaceutics company belong to?
The Diaceutics industry is Diagnostics & Research.
How many shares does Diaceutics have in circulation?
The max supply of Diaceutics shares is 84.52M.
What is Diaceutics Price to Earnings Ratio (PE Ratio)?
Diaceutics PE Ratio is now.
What was Diaceutics earnings per share over the trailing 12 months (TTM)?
Diaceutics EPS is 0 USD over the trailing 12 months.
Which sector does the Diaceutics company belong to?
The Diaceutics sector is Healthcare.